Larvol Delta - Century-Therapeutics-Announces-First-Patient-Dosed-in-FirstInHuman-Phase-1-ELiPSE1-Trial-Evaluating-CNTY101-in-Relapsed-or-Refractory-CD19-Positive-Bcell-Lymphomas

CNTY-101 - Century Therap

https://www.globenewswire.com/news-release/2023/02/08/2603834/0/en/Century-Therapeutics-Announces-First-Patient-Dosed-in-First-In-Human-Phase-1-ELiPSE-1-Trial-Evaluating-CNTY-101-in-Relapsed-or-Refractory-CD19-Positive-B-cell-Lymphomas.html

Feb 8, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next